AETHLON MEDICAL, INC.
Income Statement
| Line Item | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 |
|---|---|---|---|---|---|
| Revenue | $886.6K | $762.4K | $1.6M | $1.2M | $1.4M |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| Gross Margin | — | — | — | — | — |
| Operating Expenses | |||||
| Research & Development | $782.0K | $1.0M | $1.5M | $1.4M | — |
| SG&A Expense | $929.0K | $907.1K | $931.1K | $746.1K | $852.6K |
| Operating Income | $-4.4M | $-4.0M | $-3.1M | $-3.6M | $-3.1M |
| Operating Margin | -494.6% | -523.7% | -188.2% | -290.7% | -229.1% |
| Interest Expense | — | $349.9K | $1.3M | — | — |
| Pretax Income | — | — | — | — | — |
| Income Tax Expense | $0 | $0 | $0 | $0 | — |
| Net Income | $-4.9M | $-6.8M | $-13.4M | $-4.9M | $-8.1M |
| Net Margin | -549.6% | -891.5% | -822.6% | -397.7% | -596.6% |
| EPS (Basic) | $-0.17 | $-0.31 | $-0.86 | $-0.01 | $-0.02 |
| EPS (Diluted) | $-0.17 | $-0.31 | $-0.86 | $-0.01 | $-0.02 |
| Shares Outstanding (Basic) | 30.5M | 30.4M | 776.2M | 596.9M | 407.1M |
| Shares Outstanding (Diluted) | 30.5M | 30.4M | 776.2M | 596.9M | 407.1M |
| Dividends Per Share | — | — | — | — | — |